We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
101
Increased
2,575
Reduced
1,196
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
NeoGenomics
NEO
$2.04B
| $84.1M | ﹤0.01% |
5,763,017
+107,194
| +2% | +$1.03M |
|
1652
Viridian Therapeutics
VRDN
$2.71B
| $84.1M | ﹤0.01% |
4,576,860
+409,659
| +10% | +$6.6M |
|
1653
FuelCell Energy
FCEL
$1.74B
| $84M | ﹤0.01% |
2,332,924
+151,160
| +7% | +$2.45M |
|
1654
City Holding Co
CHCO
$2.05B
| $83.9M | ﹤0.01% |
632,471
+17,433
| +3% | +$2.19M |
|
1655
HCI Group
HCI
$2.27B
| $83.7M | ﹤0.01% |
477,702
-9,033
| -2% | -$1.42M |
|
|
NTSK
1656
Netskope Inc
NTSK
$6.21B
| $83.6M | ﹤0.01% |
7,644,168
+5,136,089
| +205% | +$52.3M |
|
1657
Summit Therapeutics
SMMT
$10.2B
| $83.6M | ﹤0.01% |
5,734,484
+22,682
| +0.4% | +$402K |
|
1658
Recursion Pharmaceuticals
RXRX
$1.66B
| $83.6M | ﹤0.01% |
22,765,940
+521,553
| +2% | +$1.74M |
|
|
TE
1659
T1 Energy
TE
$1.37B
| $83.4M | ﹤0.01% |
8,796,698
+670,434
| +8% | +$4.77M |
|
1660
Northern Oil and Gas
NOG
$2.71B
| $83.2M | ﹤0.01% |
4,583,855
+79,738
| +2% | +$1.89M |
|
1661
Enerpac Tool Group
EPAC
$1.9B
| $83M | ﹤0.01% |
2,313,166
-57,194
| -2% | -$2.01M |
|
1662
Global Net Lease
GNL
$2.04B
| $82.9M | ﹤0.01% |
9,272,540
+28,299
| +0.3% | +$265K |
|
1663
Monte Rosa Therapeutics
GLUE
$1.28B
| $82.6M | ﹤0.01% |
3,412,927
+312,682
| +10% | +$5.91M |
|
1664
Goodyear
GT
$1.71B
| $82.6M | ﹤0.01% |
12,510,722
+121,839
| +1% | +$784K |
|
1665
Sarepta Therapeutics
SRPT
$1.9B
| $82.5M | ﹤0.01% |
4,591,755
+13,520
| +0.3% | +$256K |
|
1666
Omnicell
OMCL
$1.64B
| $81.8M | ﹤0.01% |
1,970,472
+35,955
| +2% | +$1.45M |
|
1667
Walker & Dunlop
WD
$1.4B
| $81.7M | ﹤0.01% |
1,493,413
+16,098
| +1% | +$815K |
|
|
MBX
1668
MBX Biosciences
MBX
$3.2B
| $81.6M | ﹤0.01% |
1,477,388
-204
| -0% | -$7.13K |
|
|
BGSI
1669
Boyd Group Services
BGSI
$2.6B
| $81.5M | ﹤0.01% |
860,345
+10,911
| +1% | +$1.2M |
|
1670
Photronics
PLAB
$1.88B
| $81.4M | ﹤0.01% |
2,501,565
-1,526
| -0.1% | -$64.6K |
|
|
BAND
1671
Bandwidth Inc
BAND
$1.7B
| $81.3M | ﹤0.01% |
1,284,658
+89,780
| +8% | +$4.03M |
|
1672
CorVel
CRVL
$3.38B
| $81.2M | ﹤0.01% |
1,298,302
+1,310
| +0.1% | +$76.4K |
|
1673
John Wiley & Sons Class A
WLY
$2.59B
| $80.8M | ﹤0.01% |
1,666,448
-53,084
| -3% | -$2.23M |
|
|
HTFL
1674
Heartflow Inc
HTFL
$3.93B
| $80.8M | ﹤0.01% |
2,753,206
+859,711
| +45% | +$25.8M |
|
1675
Denison Mines
DNN
$2.85B
| $80.2M | ﹤0.01% |
26,152,008
+703,019
| +3% | +$2.45M |
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.1%. Vanguard Capital Management opened 101 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 101 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.